Related Experiment Video
Updated: Jun 2, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Sitafloxacin: in bacterial infections
1Adis, a Wolters Kluwer Business, Auckland, New Zealand. demail@adis.co.nz
Sitafloxacin, a broad-spectrum fluoroquinolone antibiotic, demonstrates efficacy in treating various bacterial infections. Clinical trials confirm its noninferiority to other antibiotics for pneumonia and urinary tract infections, with manageable side effects.
Area of Science:
- Pharmacology and Microbiology
- Infectious Diseases
- Clinical Trials
Background:
- Sitafloxacin is a fluoroquinolone antibiotic with broad-spectrum activity against Gram-positive, Gram-negative, anaerobic, and atypical pathogens.
- It is approved in Japan for treating numerous bacterial infections caused by susceptible strains.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of sitafloxacin in treating various bacterial infections.
- To compare sitafloxacin with other antibiotics like levofloxacin and tosufloxacin in randomized controlled trials.
Main Methods:
- Randomized, double-blind, multicentre, noninferiority trials were conducted to compare oral sitafloxacin with levofloxacin and tosufloxacin.
- Noncomparative studies assessed sitafloxacin's efficacy in specific infections like respiratory tract, urinary tract, and sexually transmitted infections.
Main Results:
- Oral sitafloxacin was found to be noninferior to oral levofloxacin for community-acquired pneumonia and complicated urinary tract infections.
- It was also noninferior to tosufloxacin for community-acquired pneumonia.
- Studies showed efficacy in otorhinolaryngological, odontogenic, and C. trachomatis-associated infections.
Conclusions:
- Sitafloxacin is a clinically effective treatment option for a range of bacterial infections, including respiratory, urinary tract, and specific gynecological and odontogenic infections.
- The most common adverse reactions were gastrointestinal disorders and laboratory abnormalities, generally of mild to moderate severity.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urine Studies II: Urine Culture and Sensitivity Test
Inhibitors of Bacterial Protein Synthesis
Urinary Tract Infection I: Introduction

